Carregant...
Risk adapted high-dose and dose-dense therapies modulate the impact of biological classification in diffuse large B-cell lymphoma prognosis
Guardat en:
Autors principals: | , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Format: | Artigo |
Idioma: | Inglês |
Publicat: |
Ferrata Storti Foundation
2014
|
Matèries: | |
Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4116846/ https://ncbi.nlm.nih.gov/pubmed/24763400 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2014.104976 |
Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|